Antigenic and immunogenic epitopes shared by human papillomavirus type 16 and bovine, canine, and avian papillomaviruses
- PMID: 1719234
- PMCID: PMC250784
- DOI: 10.1128/JVI.65.12.6862-6871.1991
Antigenic and immunogenic epitopes shared by human papillomavirus type 16 and bovine, canine, and avian papillomaviruses
Abstract
All types of papillomaviruses (PV) share common, so-called group-specific epitopes. To identify the major group-specific epitopes, we immunized 26 guinea pigs or rabbits with purified bovine PV type 1 (BPV), canine PV, or avian PV from the common chaffinch. The resulting hyperimmune sera, as well as a commercially available rabbit antiserum to BPV and seven monoclonal antibodies to BPV, were tested in an enzyme-linked immunosorbent assay with a set of 66 overlapping 20-amino-acid peptides representing the complete sequence of the major capsid proteins (L1 and L2) of human PV type 16 (HPV 16). Sera from the same animals before immunization were used as controls. The minimal reactive epitopes within each peptide were further characterized by testing of truncated peptides. The cross-reactive epitopes were clustered in two regions of L1, an internal region (at positions 171 to 235), which contained three epitopes, and the more reactive region at the carboxy terminus (at positions 411 to 475), which contained six epitopes. The most reactive of the HPV 16 broadly cross-reactive epitopes was a carboxy-terminal epitope which had the sequence DTYRF and which reacted with nine of the antisera to BPV, canine PV, or avian PV, with the commercially available rabbit antiserum to BPV, and also with a mouse monoclonal antibody to BPV. Antipeptide antisera to all of the HPV 16 L1 peptides and to the most antigenically reactive of their truncated analogs were made in guinea pigs. Antipeptide antisera reactive with BPV were obtained for three of the cross-reactive epitopes, and one of these antisera allowed highly sensitive detection of group-specific PV antigen by immunoperoxidase staining.
Similar articles
-
Human papillomavirus type 16 capsids expose multiple type-restricted and type-common antigenic epitopes.J Gen Virol. 1995 May;76 ( Pt 5):1141-53. doi: 10.1099/0022-1317-76-5-1141. J Gen Virol. 1995. PMID: 7537325
-
Human antibodies react with an epitope of the human papillomavirus type 6b L1 open reading frame which is distinct from the type-common epitope.J Virol. 1989 Feb;63(2):809-18. doi: 10.1128/JVI.63.2.809-818.1989. J Virol. 1989. PMID: 2463384 Free PMC article.
-
Expression in Escherichia coli of seven DNA fragments comprising the complete L1 and L2 open reading frames of human papillomavirus type 6b and localization of the 'common antigen' region.J Gen Virol. 1989 Mar;70 ( Pt 3):543-55. doi: 10.1099/0022-1317-70-3-543. J Gen Virol. 1989. PMID: 2471790
-
Recent advances in preclinical model systems for papillomaviruses.Virus Res. 2017 Mar 2;231:108-118. doi: 10.1016/j.virusres.2016.12.004. Epub 2016 Dec 9. Virus Res. 2017. PMID: 27956145 Free PMC article. Review.
-
Multiplicity of uses of monoclonal antibodies that define papillomavirus linear immunodominant epitopes.Immunol Res. 1997 Feb;16(1):115-9. doi: 10.1007/BF02786327. Immunol Res. 1997. PMID: 9048212 Review.
Cited by
-
Differential Antibody Response against Conformational and Linear Epitopes of the L1 Proteins from Human Papillomavirus Types 16/18 Is Observed in Vaccinated Women or with Uterine Cervical Lesions.Vaccines (Basel). 2021 May 2;9(5):442. doi: 10.3390/vaccines9050442. Vaccines (Basel). 2021. PMID: 34063178 Free PMC article.
-
mRNA instability elements in the human papillomavirus type 16 L2 coding region.J Virol. 1998 Feb;72(2):1504-15. doi: 10.1128/JVI.72.2.1504-1515.1998. J Virol. 1998. PMID: 9445054 Free PMC article.
-
Detection of antibodies against human papillomavirus (HPV) type 16 virions by enzyme-linked immunosorbent assay using recombinant HPV 16 L1 capsids produced by recombinant baculovirus.J Clin Microbiol. 1995 May;33(5):1380-2. doi: 10.1128/jcm.33.5.1380-1382.1995. J Clin Microbiol. 1995. PMID: 7615761 Free PMC article. Clinical Trial.
-
Efficient expression of the human papillomavirus type 16 L1 protein in epithelial cells by using Rev and the Rev-responsive element of human immunodeficiency virus or the cis-acting transactivation element of simian retrovirus type 1.J Virol. 1995 Sep;69(9):5607-20. doi: 10.1128/JVI.69.9.5607-5620.1995. J Virol. 1995. PMID: 7637007 Free PMC article.
-
Antibodies against papillomavirus antigens in cervical secretions from condyloma patients.J Clin Microbiol. 1993 Feb;31(2):192-7. doi: 10.1128/jcm.31.2.192-197.1993. J Clin Microbiol. 1993. PMID: 8381807 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases